Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neelu Puri

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Carcinogenesis|February 26, 2009
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancerNeelu Puri, Ravi Salgia
Cancer Treatment Reviews|July 31, 2012
Novel anticancer therapeutics targeting telomeraseMaria Ruden, Neelu Puri
Archives in Cancer Research|June 10, 2016
Clinical Challenges to Current Molecularly Targeted Therapies in Lung CancerGagan Chhabra, Ashley Eggert, Neelu Puri
Oncotarget|June 27, 2013
Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanomaRyan T Pitman, Luke Wojdyla, Neelu Puri
International Journal of Health Care Quality Assurance|January 2, 2013
Outpatient satisfaction and quality of health care in North Indian medical instituteNeelu Puri, Anil Gupta, Arun K Aggarwal, et al.
Cancers|August 23, 2020
Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer TherapyAdam Eckburg, Joshua Dein, Joseph Berei, et al.
Plos One|June 8, 2012
Knockdown of the fat mass and obesity gene disrupts cellular energy balance in a cell-type specific mannerRyan T Pitman, Jason T Fong, Penny Billman, et al.
Plos One|August 25, 2015
Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerGregory M Botting, Ichwaku Rastogi, Gagan Chhabra, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 30, 2003
Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNAMark S Eller, Guang-Zhi Li, Reza Firoozabadi, et al.
Cancers|April 3, 2021
Resistance to Molecularly Targeted Therapies in MelanomaMeet Patel, Adam Eckburg, Shahina Gantiwala, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Carcinogenesis|February 26, 2009
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancerNeelu Puri, Ravi Salgia
Cancer Treatment Reviews|July 31, 2012
Novel anticancer therapeutics targeting telomeraseMaria Ruden, Neelu Puri
Archives in Cancer Research|June 10, 2016
Clinical Challenges to Current Molecularly Targeted Therapies in Lung CancerGagan Chhabra, Ashley Eggert, Neelu Puri
Oncotarget|June 27, 2013
Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanomaRyan T Pitman, Luke Wojdyla, Neelu Puri
International Journal of Health Care Quality Assurance|January 2, 2013
Outpatient satisfaction and quality of health care in North Indian medical instituteNeelu Puri, Anil Gupta, Arun K Aggarwal, et al.
Cancers|August 23, 2020
Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer TherapyAdam Eckburg, Joshua Dein, Joseph Berei, et al.
Plos One|June 8, 2012
Knockdown of the fat mass and obesity gene disrupts cellular energy balance in a cell-type specific mannerRyan T Pitman, Jason T Fong, Penny Billman, et al.
Plos One|August 25, 2015
Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerGregory M Botting, Ichwaku Rastogi, Gagan Chhabra, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 30, 2003
Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNAMark S Eller, Guang-Zhi Li, Reza Firoozabadi, et al.
Cancers|April 3, 2021
Resistance to Molecularly Targeted Therapies in MelanomaMeet Patel, Adam Eckburg, Shahina Gantiwala, et al.
Pageof 4